12:35 EDT Gilead (GILD) near acquisition of Ouro Medicines for up to $2B, FT reports
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Buy Rating on Gilead Driven by HIV Franchise Momentum and Upside from Yeztugo and Biktarvy
- Gilead Ends Obeldesivir Filovirus Prophylaxis Trial: What It Means for GILD Investors
- 3 Best ETFs to Invest In, According to AI Analyst, 03/10/2026
- Gilead initiated with a Buy at Jefferies
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 8